Search

everythinglearnresearchcommunity

for

Search:↓

The enzymes Aldh1a2 and Aldh1a3 are involved in making retinoic acid in hair follicles and have different roles in hair growth.

The frizzy mouse and hairless rat mutations are due to changes in the Prss8 gene.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Fibre optic confocal imaging can visualize skin layers, blood vessels, and nerves in live mice.

Hair diameter can indicate protein status in malnourished children if sample location is controlled.

80% scalp hair regrowth is a successful treatment for alopecia areata.

Trichodysplasia spinulosa can occur after a heart transplant due to immunosuppressive drugs.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

JAK inhibitors offer new hope for treating severe alopecia areata.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Punctate follicular porokeratosis is a skin condition with specific features seen in hair follicles.

Ritlecitinib works well and is safe for treating alopecia areata.